Beneficial micro-organisms, isolated from various environments, can be 'domesticated' and used in agriculture, food and biotechnology. An analysis is required for new microbial strains and applications to ensure safety. Various regulatory frameworks apply and in some instances registration is required before marketing. Regulatory demands must be tuned to actual risk. 'Overregulation' could hamper the implementation of useful products, whereas the lack of appropriate oversight could negatively affect public health or the environment. There is a need for further development and consolidation of safety assessment of beneficial micro-organisms as a unique research discipline and of risk-benefit analysis where risks are weighed against benefits.
Instrumental Value of Micro-organisms
Single-celled micro-organisms were the earliest life forms on Earth and collectively have been vital in the evolution of life on this planet. They constitute the major part of the described biodiversity and make up roughly as much of the total of biomass carbon as do plants. They play indispensable roles in biogeochemical processes and transformations, e.g. in degradation of organic matter in soils contributing to nutrient recycling and in the primary production of biomass in the upper strata of oceans and lakes [1] . The gastrointestinal systems of invertebrates and vertebrates (including humans) harbour huge numbers of micro-organisms that maintain functioning of the system. The essential role of micro-organisms in the evolution of life, for supplying what has been coined 'ecosystem services' [2] and generally for health promotion in higher organisms cannot be questioned, and has been termed the 'instrumental value' of micro-organisms [3] .
For millennia, the instrumental value of microorganisms has been widely exploited by humankind in various beneficial applications such as food preservation and alcohol production. However, the relatively recent ability to isolate, culture and mass produce microorganisms in pure culture has resulted in their 'domestication' (Figure 1 ), taking advantage of special properties of different microbial strains. In this way, humankind is capable of tapping into the huge value of micro-organisms to its own benefit. For instance, use of microbes has recently expanded tremendously from food and feed fermentation and preservation, to production of specific metabolites and enzymes, for biological control of pests and diseases and for obtaining bulk biomass for animal feed [4] .
Assessing the Safety of Beneficial Micro-organisms
Evaluation of the safety of a new microbial strain and application may appear to have similarities to microbiological risk assesment (MRA) for assessing the risk for food poisoning by unintentional contamination with pathogenic microbes. However, assessing safety of a new beneficial microbe/application has fundamental differences to MRA. To begin with, potential hazards are not as easily identified. Moreover, the issue is not to quantify the risk represented by a known hazard, but to demonstrate the absence of hazards that may lead to harm. However, a true negative, e.g. the absence of human pathogenicity, can never be proven without a doubt. Therefore, there is a need to define a sufficient level of certainty for each micro-organism and application.
With respect to human health, some micro-organisms can cause infectious disease, toxicity and/or allergenicity. Indirect human harm may result from growth of spoilage microbes in food and feed commodities or in building materials. In the environment (including agricultural systems), microbes may cause disease in non-target organisms that can lead to changed community species composition and ecosystem functioning.
Safety assessment should start with a careful identification and correct taxonomic affiliation of the strain according to current phylogenies, followed by an investigation of the organism's basic biological properties. Taxonomy is a useful tool in safety assessments as a basis for comparisons with what is known about potential hazards in closely related strains and species. Thereafter, various tests for toxic or pathogenic potential using biosensors may be relevant, but can be complicated because of methodological difficulties and ambiguities when translating the results into actual risk. In many cases, procedures and guidelines for safety assessment are outlined in the pertaining regulatory frameworks. With ever-increasing knowledge and experience, generic systems and carefully compiled lists of species with a safe history, e.g. the qualified presumption of safety (QPS) system in Europe and generally recognized as safe (GRAS) in the USA are likely to contribute to simplified procedures [5] . These systems rely on a proper taxonomic identification of the isolate. Nevertheless, the safety of newly discovered isolates must always to some extent be evaluated on a case-by-case basis.
How are Development and Utilization of Microbial Agents Regulated?
Several types of regulatory systems can apply to the development and use of beneficial micro-organisms: (a) general legislation concerning occupational, consumer or environmental protection; (b) specific regulation requiring pre-market registration of new microbial products; (c) quarantine provisions aiming at protection from accidental export/import of pathogens; and (d) international conventions covering proprietary issues regarding biological and genetical resources (e.g. CBD, the United Nations Convention on Biological Diversity).
Regulatory frameworks must be in line with the actual hazards of microbes and risks connected with their use. Procedures that are too ambitious, complicated and costly ('overregulation') can unnecessarily hold back the development of useful microbiological products. Conversely, a lack of appropriate regulation could result in serious consequences for public health or for the environment.
The regulatory landscapes differ profoundly among different areas of utilization. Microbial food cultures -e.g. lactobacilli and yeasts in the production of dairy products,
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Implement fullscale production. bread and alcoholic beverages -have been used for thousands of years, where safety is presumed from experience and history of safe use, i.e. 'familiarity'. These micro-organisms are essentially unregulated, in the sense that authorization is not required and their safety should be ensured by the food manufacturers [5] . In contrast, microbial biocontrol agents (MBCAs) are strictly regulated and pre-market registration is required [6] . Data requirements are extensive and after submission of the dossier, authorization takes several years. The regulations of MBCAs present an example that conditions for one specific type of use can differ among countries. The time from submission of the dossier to registration of a new MBCA has been substantially longer in the European Union than in the USA -despite the fact that data requirements are similar -probably mainly because the procedures for assessments and registration differ [6] . It is likely that attitudes and policies have significant impacts on development and implementation of regulatory frameworks for beneficial micro-organisms. For example, Bailey et al. [7] argued that what has contributed to a lack of engagement in the promotion of MBCAs is that invertebrate animals used in biocontrol are commonly referred to as 'natural enemies' or 'beneficial organisms', whereas MBCAs are often referred to with the more negatively charged 'biopesticides' (i.e. they are 'still pesticides').
As a consequence of largely separate research disciplines and regulatory frameworks for different application areas, safety assessment of beneficial microbes has not yet been established as a unique research discipline in its own right. Research on overarching issues regarding development of more relevant and efficient methodology for determining human and environmental safety of beneficial microbes should be encouraged and promoted.
Future Perspectives: How can the Implementation of Novel Microbial Innovations and Applications be Stimulated?
In order to stimulate future development and use of beneficial micro-organisms, we consider the greatest needs with respect to research to be: Establishment and consolidation of safety assessment of beneficial micro-organisms as a unique research discipline, to a substantial extent across different application areas. Support of fundamental and applied microbiological research regarding, e.g. new and innovative ways that microbes could be used in beneficial applications and development of more efficient test methodology to assess potential pathogenicity and toxin production. Increased attention to development and implementation of risk-benefit analysis, where potential risks are evaluated in relation to obtained benefits [8] .
On the regulation and policy level, we consider that the greatest needs are:
Harmonization of the specific regulatory systems overseeing introduction and utilization of new microbial products. One important aspect is to ensure that all regulatory interventions are firmly based on up-todate knowledge regarding the fundamental properties and hazards of micro-organisms. Increased awareness and understanding in society about the indispensable role that microbes play for the evolution and maintenance of life, environmental resilience and the health properties they confer to higher organisms, including humans. 
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